CRT 2025
Late-Breaking Clinical Trials Structural and LAA
Andreas Rück, MD, PhD
Senior Consultant
Karolinska University Hospital, Sweden
Disclosure(s): Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)